EdgarLookup

Unicycive Therapeutics, Inc. — 8-K Filings

61 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Unicycive Therapeutics, Inc. (UNCY), sorted by most recent first. Each row links to the full filing on EdgarLookup. Unicycive Therapeutics, Inc. has filed 61 8-K documents with the SEC since 2019. To view all SEC filings by Unicycive Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-8 SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-25-111045 Nov 14, 2025
8-K CURRENT REPORT 0001213900-25-108847 Nov 12, 2025
8-K CURRENT REPORT 0001213900-25-102790 Oct 28, 2025
8-K CURRENT REPORT 0001213900-25-077937 Aug 18, 2025 Aug 15, 2025
8-K CURRENT REPORT 0001213900-25-077497 Aug 15, 2025
8-K CURRENT REPORT 0001213900-25-076066 Aug 14, 2025
8-K CURRENT REPORT 0001213900-25-061936 Jul 8, 2025 Jul 7, 2025
8-K CURRENT REPORT 0001213900-25-059303 Jun 30, 2025
8-K CURRENT REPORT 0001213900-25-056188 Jun 20, 2025 Jun 17, 2025
8-K CURRENT REPORT 0001213900-25-052824 Jun 10, 2025
8-K CURRENT REPORT 0001213900-25-052413 Jun 9, 2025
8-K CURRENT REPORT 0001213900-25-046244 May 21, 2025
8-K CURRENT REPORT 0001213900-25-042967 May 14, 2025
8-K CURRENT REPORT 0001213900-25-026270 Mar 31, 2025
8-K CURRENT REPORT 0001213900-25-001640 Jan 7, 2025
8-K CURRENT REPORT 0001213900-24-097145 Nov 13, 2024
8-K CURRENT REPORT 0001213900-24-096104 Nov 12, 2024 Nov 11, 2024
8-K CURRENT REPORT 0001213900-24-081531 Sep 25, 2024 Sep 24, 2024
8-K CURRENT REPORT 0001213900-24-068597 Aug 14, 2024
8-K CURRENT REPORT 0001213900-24-061355 Jul 15, 2024 Jul 9, 2024
8-K CURRENT REPORT 0001213900-24-061354 Jul 15, 2024 Jul 9, 2024
8-K CURRENT REPORT 0001213900-24-058621 Jul 2, 2024 Jun 26, 2024
8-K CURRENT REPORT 0001213900-24-056224 Jun 26, 2024 Jun 21, 2024
8-K CURRENT REPORT 0001213900-24-055436 Jun 25, 2024
8-K CURRENT REPORT 0001213900-24-054279 Jun 20, 2024
8-K CURRENT REPORT 0001213900-24-042338 May 13, 2024
8-K CURRENT REPORT 0001213900-24-027373 Mar 29, 2024 Mar 28, 2024
8-K CURRENT REPORT 0001213900-24-022623 Mar 14, 2024 Mar 13, 2024
8-K CURRENT REPORT 0001213900-24-022600 Mar 14, 2024 Mar 13, 2024
8-K 8-K 0001213900-24-015753 Feb 21, 2024
8-K CURRENT REPORT 0001213900-23-087029 Nov 14, 2023
8-K CURRENT REPORT 0001013762-23-005659 Oct 23, 2023
8-K CURRENT REPORT 0001213900-23-079139 Sep 25, 2023 Sep 19, 2023
8-K CURRENT REPORT 0001213900-23-074164 Sep 6, 2023 Sep 5, 2023
8-K CURRENT REPORT 0001213900-23-072838 Aug 31, 2023 Aug 28, 2023
8-K CURRENT REPORT 0001213900-23-067398 Aug 15, 2023 Aug 14, 2023
8-K CURRENT REPORT 0001213900-23-061295 Jul 31, 2023 Jul 25, 2023
8-K CURRENT REPORT 0001213900-23-059806 Jul 26, 2023 Jul 25, 2023
8-K CURRENT REPORT 0001213900-23-053035 Jun 30, 2023 Jun 29, 2023
8-K CURRENT REPORT 0001213900-23-051702 Jun 26, 2023
8-K CURRENT REPORT 0001213900-23-042369 May 23, 2023 May 17, 2023
8-K CURRENT REPORT 0001213900-23-040217 May 16, 2023
8-K CURRENT REPORT 0001213900-23-028383 Apr 10, 2023 Apr 6, 2023
8-K CURRENT REPORT 0001213900-23-024969 Mar 31, 2023
8-K CURRENT REPORT 0001213900-23-024274 Mar 30, 2023 Mar 28, 2023
8-K CURRENT REPORT 0001213900-23-017841 Mar 6, 2023 Mar 3, 2023
8-K CURRENT REPORT 0001213900-23-016444 Mar 2, 2023 Feb 28, 2023
8-K CURRENT REPORT 0001213900-23-008965 Feb 7, 2023 Feb 1, 2023
8-K CURRENT REPORT 0001213900-23-007404 Feb 2, 2023 Feb 1, 2023
8-K CURRENT REPORT 0001213900-22-083446 Dec 29, 2022